Advance Search
HU Xiaoli, LI Manhong, CHE Hongfang. Efficiency observation of Compound Danshen Dropping Pills, Mingmu Dihuang Pills and calcium dobesilate capsules in treating patients with diabetic retinopathy at stage Ⅲ[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 96-99. DOI: 10.7619/jcmp.201919026
Citation: HU Xiaoli, LI Manhong, CHE Hongfang. Efficiency observation of Compound Danshen Dropping Pills, Mingmu Dihuang Pills and calcium dobesilate capsules in treating patients with diabetic retinopathy at stage Ⅲ[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 96-99. DOI: 10.7619/jcmp.201919026
shu

Efficiency observation of Compound Danshen Dropping Pills, Mingmu Dihuang Pills and calcium dobesilate capsules in treating patients with diabetic retinopathy at stage Ⅲ

  • 1.

    Department of Fundus Surgery, Xi′an Aier Eye Hospital, Xi′an, Shaanxi, 710000

  • 2.

    Department of Ophthalmology, Xijing Hospital, Xi′an, Shaanxi, 710032

  • 3.

    Department of Ophthalmology, Shaanxi Provincial Rehabilitation Hospital, Xi′an, Shaanxi, 710065

More Information
  • Received Date: July 14, 2019
  • Accepted Date: September 12, 2019
  • Available Online: February 28, 2021
  • Published Date: October 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To explore the clinical effect of Compound Danshen Dripping Pills, Mingmu Dihuang Pills and calcium dobesilate capsules in the treatment of patients with diabetic retinopathy (DR) at stage Ⅲ.
      Methods  Totally 76 patients (76 eyes) with DR at stage Ⅲ were randomly divided into two groups. In the control group, 35 patients were treated with calcium dobesilate capsules on the basis of routine treatment. In the study group, 41 patients were treated with Danshen Dripping Pills and Mingmu Dihuang Pills on the basis of control group. The therapeutic effect, bleeding spot area, visual gray value, hemangioma volume and macular thickness before and after treatment were compared between the two groups. The expression levels of vascular endothelial growth factor (VEGF), retinol binding protein 4 (RBP4) and insulin growth factor-1 (IGF-1) were compared between the two groups before and after treatment.
      Results  The clinical effect of the study group was significantly better than that of the control group (P < 0.05). After treatment, the hemorrhagic plaque area, hemangioma volume and macular thickness in the study group were significantly smaller than those in the control group, and the visual gray value and logMAR visual acuity were significantly lower than those in the control group (P < 0.05). After 1, 2 and 3 months of treatment, the serum levels of VEGF, RBP4 and IGF-1 in both groups showed a significant downward trend (P < 0.05), and the above indexes in the study group were significantly lower than those in the control group (P < 0.05).
      Conclusion  Combination of compound Danshen dropping pills, Mingmu Dihuang pills and calcium dobesilate are effective in the treatment of patients with DR at stage Ⅲ, which can effectively inhibit the angiogenesis mediated by various cytokines in retina, improve fundus symptoms and visual acuity of patients.
    • FullText(HTML)
    • References (16)
  • [1]
    Schmidt J, Peters S, Sauer L, et al. Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy[J]. Acta Ophthalmologica, 2016, 95(1): 33-40. doi: 10.1111/aos.13174/abstract
    [2]
    宁顺宇, 郜贺, 杨宇峰, 等.川芎嗪联合用药治疗糖尿病视网膜病变的系统评价[J].中华中医药学刊, 2017, 35(9): 215-220. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201709062.htm
    [3]
    张哲, 刘竹青, 刘巨平, 等.二甲双胍联合抗血管内皮生长因子药物治疗糖尿病视网膜病变的可能协同作用[J].中华眼底病杂志, 2018, 34(5): 453-457. doi: 10.3760/cma.j.issn.1005-1015.2018.05.008
    [4]
    Feghhi M, Farrahi F, Abbaspour M, et al. Effect of Adding Oral Calcium Dobesilate to Laser Photocoagulation on the Macular Thickness in Patients with Diabetic Macular Edema: A Randomized Clinical Trial[J]. Advanced Pharmaceutical Bulletin, 2014, 4(4): 375-378. http://pubmedcentralcanada.ca/pmcc/articles/PMC4137428/
    [5]
    王珩.非诺贝特联合羟苯磺酸钙治疗T2DM合并NPDR的疗效[J].实用临床医学, 2016, 17(12): 1-3. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSY201612001.htm
    [6]
    陈利荣, 姚军平, 张贻转, 等.羟苯磺酸钙联合GLP-1类似物治疗糖尿病视网膜病变的临床意义[J].中国医院药学杂志, 2017, 37(15): 1505-1508. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ201715022.htm
    [7]
    蔡萧君, 王丽媛, 赵晓龙.养阴活血明目法治疗单纯性糖尿病视网膜病变临床研究[J].中医学报, 2017, 32(12): 2359-2362. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201712022.htm
    [8]
    马京平.复方血栓通胶囊联合羟苯磺酸钙治疗早期糖尿病性视网膜病变[J].国际眼科杂志, 2018, 18(2): 305-308. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201802029.htm
    [9]
    中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志, 2014, 50(11): 851-865. doi: 10.3760/cma.j.issn.0412-4081.2014.11.014
    [10]
    殷俏, 张云良, 郭淑芹, 等.视黄醇结合蛋白4、超敏C反应蛋白与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志, 2016, 36(3): 149-152, 156.
    [11]
    韩琳娜, 李一梅, 谢波.复方丹参滴丸治疗非增生期糖尿病视网膜病变的研究进展[J].中成药, 2015, 37(2): 382-384. doi: 10.3969/j.issn.1001-1528.2015.02.033
    [12]
    马梦瑾, 田晨光, 赵志刚, 等.复方丹参滴丸治疗早期糖尿病视网膜病变的疗效[J].世界中医药, 2016, 11(3): 450-453. doi: 10.3969/j.issn.1673-7202.2016.03.021
    [13]
    阮余霞, 陈明, 刘志谦, 等.口服复方丹参滴丸联合羟苯磺酸钙治疗糖尿病患者视网膜病变的临床研究[J].中南医学科学杂志, 2017, 45(1): 18-20, 23. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY201701004.htm
    [14]
    徐赵钕, 章仕淼, 刘玲玲.明目地黄丸对糖尿病视网膜病变大鼠细胞自噬及Akt-mTOR通路的影响[J].中国医药导报, 2018, 15 (20): 22-26, 38. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201820005.htm
    [15]
    汪洋.明目地黄丸和三七血伤宁胶囊联合西医治疗非增殖期2型糖尿病性视网膜病变的观察[J].中国中医急症, 2016, 25(12): 2345-2348. doi: 10.3969/j.issn.1004-745X.2016.12.043
    [16]
    黄菁, 王丽波, 刘俐利.羟苯磺酸钙联合芪明颗粒治疗对非增殖期糖尿病视网膜病变患者脉络膜以及血清支链氨基酸、细胞因子的影响[J].海南医学院学报, 2016, 22(18): 2202-2205. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201618037.htm
    • Related Articles

  • Related Articles

    [1]LI Hongli, YAN Huili. Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 106-111. DOI: 10.7619/jcmp.20233856
    [2]ZHOU Lina, HAN Yanhua, GENG Tiantian, LIU Li. Research progress in effects of hyperandrogenin and insulin resistance on placental pathology of polycystic ovary syndrome
    [J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 137-141. DOI: 10.7619/jcmp.20223478
    [3]DONG Yaguang, ZHU Lin, CHEN Haoyang. Research progress of complications of polycystic ovary syndrome in obstetric department and mechanisms[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 112-116. DOI: 10.7619/jcmp.20214639
    [4]CHEN Haixia, LI Jian, WU Fengyun, BAI Yueran, GU Bei, SONG Xiaohong, SUN Yu, CUI Guangxia, WANG Zijun, WANG Xiaoxue, YIN Cong, YANG Mukun, FAN Li, BAI Wenpei, JIANG Bo. Clinical pathway of ketogenic diet in the treatment of patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 5-7,32. DOI: 10.7619/jcmp.20210722
    [5]JIA Xiaolin, LI Na. Clinical efficiency of laparoscopic ovarian perforation combined with clomiphene citrate and human chorionic gonadotropin in treating infertility induced by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 102-105. DOI: 10.7619/jcmp.201907027
    [6]BAI Liran, LI Jian, NIU Litian, WANG Aili, WU Fengyun, BAI Wenpei, JIANG Bo. Preliminary report of a single-center clinical study for ketogenic diet intervention of polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 2-5. DOI: 10.7619/jcmp.201907002
    [7]BAO Xudong, XU Yang, FU Rong. Effect of ethinylestradiol and cyproterone acetate tablets combined with metformin on hormone levels of patients with sterility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (1): 104-106,110. DOI: 10.7619/jcmp.201801032
    [8]MAYILA · Maimaiti, ZULIPIYA · Yiming. Clinical effect of clomiphene combined with human chorionic gonadotropin on ovulation induction in infertility patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2017, (17). DOI: 10.7619/jcmp.201717021
    [9]YIN Jiayao, YANG Ying. Study on modified ultra-long protocol in improving endometrial receptivity in infertile patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (23): 75-77,81. DOI: 10.7619/jcmp.201623022
    [10]CAI Xiuli, YAO Jinyan, ZHANG Yijiao. Effect of Diane-35 combined with clomiphene on treatment of infertility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (15): 60-62. DOI: 10.7619/jcmp.201615017

  • Cited by

    Periodical cited type(14)

    1. 季晓丽，卢莹莹，赵小瑞. 酶联免疫法和金标法对HIV抗体的检测结果比较. 临床医学工程. 2024(03): 337-338 .
    2. 吴瑕. 化学发光免疫分析法与酶联免疫法检测艾滋病抗体的效果研究. 黑龙江中医药. 2023(02): 362-364 .
    3. 张婷婷. 溶血标本对化学发光免疫分析法检测HIV抗体检验结果的影响. 中国现代医生. 2022(08): 107-110 .
    4. 张缤月. 酶联免疫吸附法和实时荧光定量PCR法检验EB病毒的效果比较. 中国实验诊断学. 2022(07): 1078-1081 .
    5. 马伟刚. 溶血标本在应用化学发光免疫分析法检测HIV抗体时对检测结果的影响. 临床研究. 2022(09): 125-128 .
    6. 万琴. 不同免疫检验法抗HIV检测结果对比. 基层医学论坛. 2022(26): 55-57 .
    7. 江洋. 临床检验中化学发光免疫分析的应用效果分析. 中国实用医药. 2022(21): 87-89 .
    8. 王旭. 分析电化学发光免疫法与酶联免疫吸附试验法检测人类免疫缺陷病毒的临床效果. 中国实用医药. 2021(04): 46-48 .
    9. 刘凤. 艾滋病病毒感染实验检测方法研究进展. 应用预防医学. 2021(02): 185-188+193 .
    10. 张晨磊. 化学发光免疫分析法的研究进展. 医疗装备. 2021(14): 191-192 .
    11. 蔡贤惠. 电化学发光免疫分析与酶联免疫吸附试验检测甲型肝炎病毒Ig M抗体的对比评价. 中国医药指南. 2021(23): 74-75 .
    12. 武红斌. 不同酶免检测试剂检测抗HIV的结果比较. 临床医学研究与实践. 2020(24): 113-115 .
    13. 赵鸿翔. 人类免疫缺陷病毒抗体采用酶联免疫吸附法及电化学发光免疫分析法检测的效果. 中国医疗器械信息. 2020(24): 85-86 .
    14. 严建明，何宝贤，刘玉华. 酶联免疫法筛查HIV抗体应用于诊断艾滋病价值观察. 实用妇科内分泌电子杂志. 2020(18): 156+158 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (291) PDF downloads (12) Cited by(16)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return